Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Indian J Ophthalmol ; 2011 July; 59(4): 312-314
Article in English | IMSEAR | ID: sea-136198

ABSTRACT

We report an unusual presentation of a case of Axenfeld-Rieger (A-R) syndrome. A 14-year-old male presented with gradual dimness of vision for 1 year and redness of left eye for 3 days. The patient had megalocornea with Haab's striae in the right eye and posterior embryotoxon in both the eyes. In the left eye, there was a white cord-like structure traversing the anterior chamber with adhesions to iris tissue along its course. On two antiglaucoma medications, his intraocular pressure (IOP) was 22 mm Hg in the right eye and 18 mm Hg in the left eye. Gonioscopy revealed a cord-like structure originating at the level of Schwalbe's line. He underwent right eye trabeculectomy with mitomycin-C. This case highlights a rare presentation of a strange cord-like structure, a rare presentation of A-R syndrome.


Subject(s)
Adolescent , Anterior Chamber/pathology , Anterior Eye Segment/abnormalities , Anterior Eye Segment/pathology , Anterior Eye Segment/physiopathology , Anterior Eye Segment/surgery , Cornea/abnormalities , Eye Abnormalities/pathology , Eye Abnormalities/physiopathology , Eye Abnormalities/surgery , Gonioscopy , Humans , Intraocular Pressure , Iris/pathology , Male , Mitomycin/therapeutic use , Tissue Adhesions/pathology , Trabeculectomy , Vision Disorders/etiology
2.
Indian J Ophthalmol ; 2011 Jan; 59 (Suppl1): 158-160
Article in English | IMSEAR | ID: sea-136267

ABSTRACT

Glaucoma is one of the leading causes of blindness worldwide. Various randomized controlled clinical trials have shown that lowering intraocular pressure (IOP) does reduce progression of primary open-angle glaucoma. However, there is lots of interest in nonpharmacological options that includes lifestyle adjustment and alternative and complementary therapy (ACT). At least 5% glaucoma population uses ACT. Various lifestyle activities like exercise and alcohol can reduce IOP by 1 to 2 mm Hg but would have small effect on glaucoma. The psychological stress can increase IOP. Hypothetically and few studies do show neuroprotective effect (or effect on ocular blood flow) of alcohol, Gingko biloba, bilberry, but the current evidence is weak for its routine use. We must also remember the side effects of ‘medications’ (e.g., marijuana, alcohol) before promoting as remedy for glaucoma. In current armamentarium of glaucoma management, ACT cannot substitute the conventional treatment available to lower IOP.


Subject(s)
Alcoholic Beverages/adverse effects , Antioxidants/administration & dosage , Cannabis/adverse effects , Complementary Therapies/methods , Diet , Ginkgo biloba , Glaucoma/physiopathology , Glaucoma/therapy , Glaucoma, Open-Angle/therapy , Humans , Intraocular Pressure , Life Style , Neuroprotective Agents/therapeutic use , Vaccinium myrtillus
3.
Indian J Ophthalmol ; 2009 Jul; 57(4): 313-314
Article in English | IMSEAR | ID: sea-135969

ABSTRACT

We report a case of aniridia associated with congenital aphakia and secondary glaucoma. A 35-year-old male presented with aniridia, congenital aphakia and secondary glaucoma in both eyes. After an unsuccessful medical management, he underwent trabeculectomy with mitomycin C and anterior vitrectomy under local anesthesia in his left eye. Postoperatively, at the end of six months, intraocular pressure (IOP) in his left eye was controlled without medications. This case highlights the rare association of aniridia with congenital aphakia and secondary glaucoma.


Subject(s)
Adult , Aniridia/complications , Aniridia/surgery , Aphakia/complications , Aphakia/congenital , Glaucoma/complications , Glaucoma/etiology , Glaucoma/physiopathology , Glaucoma/surgery , Humans , Male , Optic Atrophy/etiology , Postoperative Period , Trabeculectomy , Visual Acuity
4.
Indian J Ophthalmol ; 2008 May-Jun; 56(3): 223-30
Article in English | IMSEAR | ID: sea-72023

ABSTRACT

Primary open angle glaucoma (POAG) is usually a chronic, slowly progressive disease. At present, all resources are directed towards reduction of intraocular pressure (IOP), the only known causal and treatable risk factor for glaucoma, and medical management is frequently the first choice in most cases. With the introduction of innovative tools for early diagnosis and newer medications for treatment, decision-making in diagnosis and treatment of glaucoma has become more complex. The philosophy of glaucoma management is to preserve the visual function and quality of life (QOL) of the individual with minimum effects on QOL in terms of cost, side effects, treatment regime, follow-up schedules as well as socioeconomic burden. Our aim should be not to treat just the IOP, optic disc or visual field, but to treat the patient as a whole so as to provide maximum benefit with minimal side effects. In this article, we describe the scientific approach to medical management, mainly of POAG.


Subject(s)
Antihypertensive Agents/therapeutic use , Diagnostic Techniques, Ophthalmological , Glaucoma, Open-Angle/diagnosis , Humans , Intraocular Pressure/drug effects , Ocular Hypertension/diagnosis , Practice Guidelines as Topic
SELECTION OF CITATIONS
SEARCH DETAIL